Open Government Portal

Found 10 records similar to Drug and vaccine authorizations for COVID-19: List of authorized drugs, vaccines and expanded indications

Federal

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed in this document.

Last Updated: Nov. 8, 2021
Date Published: Sep. 16, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Coronavirus, disease, COVID-19, COVID, health, product, industry, Drugs, vaccines
Federal

Drugs and vaccines that have been authorized by Health Canada for use in relation to the COVID-19 pandemic are listed here.

Last Updated: Aug. 26, 2021
Date Published: Jul. 30, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, drug, vaccine, drug and vaccine authorizations, list of authorized drugs, list of authorized vaccines, expanded indications
Federal

The tables below list the COVID-19-related clinical trials which have been authorized by Health Canada through the Food and Drug Regulations or the Interim order No. 2 for clinical trials for medical devices and drugs related to COVID-19.

Last Updated: Jul. 27, 2021
Date Published: Jun. 14, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, vaccines for COVID-19, drugs for COVID-19, list of authorized clinical trials
Federal

How Health Canada is addressing clinical trials of drugs and vaccines, its expedited review process and the Special Access Program to find therapies to prevent or treat COVID-19.

Last Updated: Jul. 27, 2021
Date Published: May 3, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, vaccines for COVID-19, drugs for COVID-19
Federal

COVID-19 vaccine ingredients in the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.

Last Updated: May 28, 2021
Date Published: May 7, 2021
Organization: Public Health Agency of Canada
Formats: HTML
Keywords:  Covid-19, pandemic, covid vaccine, Pfizer covid vaccine, Pfizer COVID-19 vaccine, Moderna covid vaccine, Moderna COVID-19 vaccine, AstraZeneca covid vaccine, AstraZeneca COVID-19 vaccine
Federal

The list below includes all applications received by Health Canada for drugs and vaccines used for the COVID-19 pandemic. This list includes applications received under the interim order and those received under the Food and Drug Regulations. The current status of each application is also noted.

Last Updated: Jun. 30, 2021
Date Published: Jun. 9, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, drug, vaccine, drug authorizations for COVID-19, vaccine authorizations for COVID-19, list of applications, interim order, Food and Drug Regulations
Federal

The tables below list the COVID-19-related clinical trials which have been authorized by Health Canada through the Food and Drug Regulations or the Interim order No. 2 for clinical trials for medical devices and drugs related to COVID-19.

Last Updated: Sep. 24, 2021
Date Published: Sep. 8, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, drugs and vaccines, medical devices, authorized clinical trials, COVID-19 clinical trials, COVID-19 vaccines, Food and Drug Regulations, Interim order No.2
Federal

We are collaborating with other national regulatory authorities to align the requirements for evaluating, authorizing and post-market surveillance of variant COVID-19 vaccines as much as possible.

Last Updated: Jul. 28, 2022
Date Published: Mar. 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, SARS-CoV-2 virus, COVID-19 vaccines, COVID-19 drugs, market authorization requirements, vaccine manufacturers, requirements for vaccines, SARS-CoV-2 variants
Federal

Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.

Last Updated: Jul. 27, 2021
Date Published: Mar. 26, 2021
Organization: Health Canada
Formats: HTML
Keywords:  coronavirus, COVID-19, pandemic, drugs, medications, vaccines, market authorization, licensing, importing or selling
Federal

This document provides guidance to vaccine manufacturers seeking authorization for their vaccine that targets the SARS-CoV-2 virus. This guidance applies to applications under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19.

Last Updated: Jul. 28, 2022
Date Published: Nov. 18, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, SARS-CoV-2 virus, COVID-19 vaccines, COVID-19 drugs, market authorization requirements, vaccine manufacturers, importation, sale and advertising
Date modified: